Special Issue "Antivirals and Vaccines: Molecular Research in Treatment and Prevention"
Deadline for manuscript submissions: 29 February 2024 | Viewed by 1517
Interests: HIV; antivirals and vaccines; drug resistance; pathogenesis; antibody neutralization; virus evolution
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Molecular Sciences: Antivirals and Vaccines
Special Issue in Viruses: Host-Directed Therapies for HIV and RNA Respiratory Virus Infections
Special Issue in International Journal of Molecular Sciences: Current Advances in Antivirals and Vaccines
As the HIV, HCV and SARS-Cov-2 pandemics well illustrate, antivirals or vaccines have been crucial to control transmission, prevent disease progression and avert a very significant number of deaths caused by viral infections. However, vaccines are still not available for most virus infections and diseases including those caused by HIV and HCV. Likewise, a very limited number of drugs is currently available to treat deadly viral infections such as lower respiratory infections caused by RSV, influenza viruses and coronaviruses. Moreover, drug resistance is increasing in certain viruses such as HIV threatening the success obtained so far in controlling this pandemic. New and better antiviral drugs are in need to fight this global public health threat. This special issue of the International Journal of Molecular Sciences seeks to attract top level publications on the design, development and validation of new antivirals and vaccines to treat and prevent human viral diseases. We invite you to share with us your most insightful primary research work, reviews, and hypothesis on these important topics.
Prof. Dr. Nuno Taveira
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antiviral drugs
- broad-spectrum antivirals
- neutralizing antibodies
- drug targets and mechanism of action
- drug resistance
- antiviral vaccines
- vaccine immunogens
- immunogen design
- mRNA vaccines
- self-amplifying mRNA vaccines
- vaccine adjuvants
- animal models